INTRODUCTION
============

Malaria is a protozoan disease transmitted by mosquitos. This disease shows various clinical manifestations from mild fever to death according to the *Plasmodium* species. Sometimes malaria is accompanied by severe complications such as cerebral malaria, renal failure, jaundice or abnormal bleeding.[@ref1] Among the complications, reports of malaria-associated splenic infarctions are rare.[@ref2] Fortunately, most of the cases reported that patients recovered with conservative management without surgery.[@ref3] However, most of the case reports did not describe the patients' status after discharge from the hospital. Here we present a case in which a man suffered from malaria-induced splenic infarction with serial follow-up.

CASE
====

A 28-year-old man fulfilling his military service near the Korean Demilitarized Zone (DMZ) and did not have oversea travel records within 6 months was referred to the emergency room for fever which began 1 week ago. He suffered upper abdominal pain for 2 days. His last taking of anti-malarial drug for chemoprophylaxis was 2 years ago. At the time of his visit to the emergency room, he experienced a fever spiking up to 39.8°C. Blood pressure was 131/74 mm Hg, respiratory rate was 16 breaths/min and heart rate was 87 beats/min. His numeric pain rating scale was 3. However, abdominal palpation revealed no tenderness. An initial blood sample objectified the following results: white blood cell count of 8870/ml, C-reactive protein level of 11.43 mg/dl, platelet count of 57000/ml, total bilirubin level of 1.8 mg/dl, aspartate aminotransferase (AST) level of 83 IU/L, alanine aminotransferase (ALT) level of 181 IU/L, alkaline phosphatase level of 249 IU/L, and gamma-glutamyl transpeptidase level of 70 IU/L. In the computed tomography (CT), hepatomegaly was shown and splenomegaly (about 16 cm) with low attenuation density suggesting splenic infarction was shown ([Fig 1A, B](#F1){ref-type="fig"}). Because red blood cells infected by plasmodium species were shown in the peripheral blood smear, he was admitted with malaria infection. In addition, because there was no definite tenderness around the patient's abdomen from physical examination, we decided to perform conservative care without surgical treatment. The patient was given oral chloroquine (25 mg/kg in 3 days) on the day of admission. On hospital day (HOD) 3, *P. vivax* was detected in the patient's malaria PCR test.

After conservative management, the patient's condition improved. His fever subsided on HOD 3. Although AST and ALT increased up to about 200 on HOD 4, (AST: 151 IU/L, ALT: 217 IU/L) his laboratory findings were getting better ([Table 1](#T1){ref-type="table"}). The patient was discharged on HOD 15 without any symptoms. At this time, another malaria PCR test showed negative findings and the patient's spleen size decreased to the upper limit of normal size (13 cm) in the abdominal ultrasonography ([Fig. 1C](#F1){ref-type="fig"}). At discharge, oral primaquine (15 mg/day) was prescribed. The patient visited the outpatient department on HOD 30 and 60, respectively. Although low attenuation density still appeared in the following CT, the lesion decreased compared to initial image and the size of the spleen decreased to normal range on HOD 30 ([Fig. 1D](#F1){ref-type="fig"}). On HOD 60, the patient's ultrasonography did not show any specific finding and his clinical examination and liver profile was normal ([Fig. 1E](#F1){ref-type="fig"}).

DISCUSSION
==========

Although the Republic of Korea (ROK) once was declared malaria free by the World Health Organization, malaria reemerged in 1993 and is still prevalent near the DMZ.[@ref4],[@ref5] One reason of reemergence is climate change. Some articles showed that temperature likely played a role in the dynamics of malaria transmission in the ROK.[@ref4] Another reason is the geopolitical characteristic of ROK. In ROK, vector control near the DMZ is difficult due to Democratic People's Republic of Korea.[@ref6]

To prevent the spread of malaria, ROK initiated chemoprophylaxis with anti-malarial drug (hydroxychloroquine and primaquine phosphate) among military personnel assigned to areas at high risk for malaria (mainly near DMZ).[@ref7] As a result, the incidence of malaria in the ROK has decreased. However, one interesting point is that severe malaria cases increased significantly over time.[@ref8] Although, the exact reason for the increase is uncertain, some studies explain this feature is due to resistance of anti-malarial drug or a change in the *P. vivax* strain.[@ref8],[@ref9] With this trend, malaria-induced splenic infarction has increased.

Although the pathogenesis is not clearly revealed, several factors such as vascular congestion and occlusion, hypercoagulable state and anemic hypoxia are suggested to induce malaria-induced splenic infarction.[@ref2] Therefore, this infarction is a transient feature. The patient condition improved resulting in better flow of the spleen. Actually, without splenic rupture, most of the malaria-induced splenic infarction could be cured with only conservative care. In our case, improving splenomegaly and decreasing low attenuation density were shown as time went on. However, if the spleen was ruptured, some patients should undergo a splenectomy, which may lead to a mortality rate of up to 15%.[@ref10] Therefore, it appears to be important to detect the splenic infarction and treat the malaria early. In the meantime, surgeons should pay attention to the probability of spleen rupture that might require splenectomy.

To sum up, with the change of the times, malaria-induced splenic infarction could increase and many surgeons could experience similar cases. Our case is a typical case that reflects the background of recent ROK and is meaningful to serially show the clinical course of the patient who experienced malaria-induced splenic infarction with various imaging modalities.

In conclusion, although malaria induced splenic infarction is still rare the rate might increase. Therefore, surgeons should be interested in its complications and clinical manifestations to make a decision for the patients.
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![Serial follow-up image studies of the patient. (A) Initial: hepatomegaly and splenomegaly with focal splenic infarction (white wedge), (B) Initial: focal low attenuation density at spleen, (C) HOD 15: decreased spleen size to upper limit of normal, (D) HOD 30: decreased pathologic lesion compared to initial image, (E) HOD 60: decreased spleen size to normal range.](AHBPS-24-239-f1){#F1}
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Biological parameters of the patient

  HOD (day)        1       2      3      4      5      8       12     15     30     60
  ---------------- ------- ------ ------ ------ ------ ------- ------ ------ ------ ----
  WBC (10^3^/μl)   8.87    8.36   7.71   8.01   8.49   10.43   7.62   8.59   6.29   
  Neutrophil (%)   48.7    43.0   34.6   30.4   30.8   53.9    43.4   51.4   40.3   
  Plt (10^3^/μl)   57      80     79     114    168    292     305    271    253    
  CRP (mg/dl)      11.43   9.12                 2.53   0.45                         
  T. bil (mg/dl)   1.8     1.1    1.3    1.1    0.6    0.8     1.0    0.9    0.8    
  AST (IU/L)       83      69     93     151    126    79      42     44     33     45
  ALT (IU/L)       181     149    167    217    216    213     116    86     72     35
  ALP (IU/L)       249     240    212    241    269    244     240    266    256    

HOD, hospital day; WBC, white blood cell; Plt, platelet; CRP, C-reactive protein; T. bil, total bilirubin; AST, aspartate amiotransferase; ALT, alanine transaminase; ALP, alkaline phosphatase
